Medimmune köper bolag

Förvärvar kolesterolbolag i USA.

By Nyhetsbyrån Direkt

April 3, 2013 12:00 AM

STOCKHOLM (Direkt) Astrazenecas dotterbolag, biologiläkemedelsbolaget Medimmune, köper det amerikanska bioteknikbolaget Alphacore. Det framgår av ett pressmeddelande.

Alphacores huvudsakliga tillgång är forskningsprojektet ACP-501 mot bland annat höga kolesterolvärden. Förra året redovisades positiva fas 1-resultat kring ACP-501.

Henrik Svensson +46 8 5191 7924

Nyhetsbyrån Direkt

{{ comments.count === 1 ? '1 comment' : comments.count > 1 ? '{0} comments'.replace('{0}', comments.count) : 'Write a comment' }}

By submitting the comment you accept the terms. See terms

Good comment behavior

Keep a good tone in your comments, avoid personal attacks and posts of marketing character. Apply only link on your comment if it is relevant to the debate.

Be aware that the debates are moderated by the portal's editorial team.

The comment has been created.

Your comment will not be visible until you activate it. In a few moments you will receive an email where you must click on a link to activate your comment.